Lin Health
United States
- Denver, Colorado
- 10/12/2025
- Series A
- $11,000,000
Lin Health partners with payers and providers to help people reclaim their lives from chronic pain through human-led, tech-enabled, highly personalized care. Our award-winning, comprehensive approach applies the latest neuroscience to treat conditions as diverse as migraines, IBS, and back and joint pain.
We partner with health systems, clinics, and payers as an integrated extension of the care team to offer patients an affordable, immediately accessible, and non-pharmacological solution for highly prevalent neuroplastic pain. Our clinically validated intervention targets the nervous system by combining the most effective pain signaling techniques, incorporating multidisciplinary clinical guidance, high-frequency coaching, evidence-based digital resources, and proprietary technology to improve patient outcomes, patient and provider satisfaction, and clinic success.
Our proprietary AI-based Care Platform provides rapid scalability and has served thousands of patients in the past 12-months. Lin Health was founded by industry veterans and is funded by leading investors.
- Industry Medical Practice
- Website https://www.lin.health/
- LinkedIn https://www.linkedin.com/company/lin-health/
Niobium Microsystems | $23,000,000 | (Dec 10, 2025)
Corma | $4,069,327 | (Dec 10, 2025)
Scowtt | $12,000,000 | (Dec 10, 2025)
AnySignal | $24,000,000 | (Dec 10, 2025)
AllScale | $5,000,000 | (Dec 10, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)
Opine | $5,000,000 | (Dec 10, 2025)
Rotostitch | $1,000,000 | (Dec 10, 2025)
Diald AI | $3,750,000 | (Dec 10, 2025)
Tuhk Inc. | $6,000,000 | (Dec 10, 2025)